Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Follicular × spartalizumab × 1 year × Clear all

Sponsor

Conditions

Melanoma 9 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 6 Colorectal Neoplasms 6 Stomach Neoplasms 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Nasopharyngeal Carcinoma 4 Neoplasm Metastasis 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Solid Tumors 2 Solid Tumor 2 Skin Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer 2 Leukemia, Myelomonocytic, Chronic 2 Glioblastoma 2 Esophageal Squamous Cell Carcinoma 2 Breast Neoplasms 2 Advanced Solid Tumors 2 von Hippel-Lindau Disease 1 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1

Interventions

Rituximab 47 Cyclophosphamide 47 Lenalidomide 39 fludarabine 24 obinutuzumab 23 Bendamustine Hydrochloride 18 Magnetic Resonance Spectroscopy 17 fludarabine phosphate 15 Vincristine 15 Prednisone 15 Specimen Handling 14 Doxorubicin 14 zanubrutinib 12 Biopsy 12 ibrutinib 11 tazemetostat 10 venetoclax 9 Whole-Body Irradiation 8 pembrolizumab 7 Peripheral Blood Stem Cell Transplantation 7 Etoposide 7 Mycophenolic Acid 6 CT-P10 6 axicabtagene ciloleucel 5 R-CHOP protocol 5 tisagenlecleucel 4 Therapeutics 4 Stem Cell Transplantation 4 Radiotherapy 4 Prednisolone 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡